2025. Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients with Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure. Voprosy onkologii. 71, 5 (Nov. 2025), OF-2520. DOI:https://doi.org/10.37469/0507-3758-2025-71-5-OF-2520.